Development of potent water-soluble inhibitors of the DNA-dependent protein kinase (DNA-PK)

被引：0
|
作者：
Cano, C. [1 ]
Curtin, N. J. [1 ]
Golding, B. T. [1 ]
Haggerty, K. [1 ]
Hardcastle, I. R. [1 ]
Hummersone, M. [2 ]
Menear, K. [2 ]
Richardson, C. [2 ]
Smith, G. C. M. [2 ]
Griffin, R. J. [1 ]
机构：
[1] No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
[2] KuDOS Pharmaceut Ltd, Cambridge, England
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72059-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：41 / 42
页数：2
相关论文
共 50 条
  • [31] Preclinical characterization of the selective DNA-dependent protein kinase (DNA-PK) inhibitor VX-984 in combination with chemotherapy
    Boucher, D.
    Hillier, S.
    Newsome, D.
    Wang, Y.
    Takemoto, D.
    Gu, Y.
    Markland, W.
    Hoover, R.
    Arimoto, R.
    Maxwell, J.
    Fields, S. Z.
    Charifson, P.
    Penney, M. S.
    Tanner, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [32] The DNA-activated protein kinase - DNA-PK
    Anderson, CW
    Carter, TH
    MOLECULAR ANALYSIS OF DNA REARRANGEMENTS IN THE IMMUNE SYSTEM, 1996, 217 : 91 - 111
  • [33] DNA ligase I activation during repair of alkylation damaged DNA is via DNA-dependent protein kinase (DNA-PK) mediated phosphorylation
    Bhat, KR
    Benton, BJ
    Ray, R
    FASEB JOURNAL, 1999, 13 (07): : A1453 - A1453
  • [34] A novel, selective inhibitor of DNA-dependent protein kinase (DNA-PK) potentiates the effects of DNA-damaging therapies in hepatocellular carcinoma
    Willoughby, Catherine E.
    Thomas, Huw D.
    Rennison, Tommy
    Cano, Celine
    Reeves, Helen L.
    Wedge, Stephen R.
    CANCER RESEARCH, 2017, 77
  • [35] DNA-dependent protein kinase (DNA-PK) phosphorylates nuclear DNA helicase II/RNA helicase A and hnRNP proteins in an RNA-dependent manner
    Zhang, SS
    Schlott, B
    Görlach, M
    Grosse, F
    NUCLEIC ACIDS RESEARCH, 2004, 32 (01) : 1 - 10
  • [36] 2,6-disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-dependent protein kinase (DNA-PK)
    Hollick, JJ
    Golding, BT
    Hardcastle, IR
    Martin, N
    Richardson, C
    Rigoreau, LJM
    Smith, GCM
    Griffin, RJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (18) : 3083 - 3086
  • [37] Discovery of Novel Heterotricyclic Compounds as DNA-Dependent Protein Kinase (DNA-PK) Inhibitors with Enhanced Chemosensitivity, Oral Bioavailability, and the Ability to Potentiate Cancer Immunotherapy
    Cheng, Binbin
    Shi, Yaru
    Shao, Chuxiao
    Wang, Shuanghu
    Su, Zhenhong
    Liu, Jin
    Zhou, Yingxing
    Fei, Xiaoting
    Pan, Wei
    Chen, Jianjun
    Lu, Yiyu
    Xiao, Jian
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (08) : 6253 - 6267
  • [38] Design and synthesis of novel pyridopyrimidin-4-one and quinolin-4-one DNA-dependent protein kinase (DNA-PK) inhibitors.
    Griffin, RJ
    Barbeau, OR
    Golding, BT
    Hardcastle, IR
    Smith, GC
    Richardson, C
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9051S - 9051S
  • [39] Visualizing functional dynamicity in the DNA-dependent protein kinase holoenzyme DNA-PK complex by integrating SAXS with cryo-EM
    Hammel, Michal
    Rosenberg, Daniel J.
    Bierma, Jan
    Hura, Gregory L.
    Thapar, Roopa
    Lees-Miller, Susan P.
    Tainer, John A.
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2021, 163 : 74 - 86
  • [40] Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes
    Shao, RG
    Cao, CX
    Zhang, HL
    Kohn, KW
    Wold, MS
    Pommier, Y
    EMBO JOURNAL, 1999, 18 (05): : 1397 - 1406
12345